What Happens To BioSante Pharmaceuticals Now? |
![]() |
![]() |
By Staff and Wire Reports | |
Friday, 20 April 2012 06:43 | |
![]() Stephen M. Simes, BioSante’s president & CEO sat down for a revealing video interview with BioMedReports and explains, quite candidly, what happened and where his firm is headed now. “We expect to meet with the FDA and be able to announce the next steps for LibiGel, which is, still quite an interesting opportunity because today as you know there is no product approved for the treatment of female sexual dysfunction.” Simes is expected to present a corporate update at the BioCentury Future Leaders in the Biotech Industry Conference in New York today at 11:00 am EDT. In the meantime, the revealing interview can be seen below. Disclosure: None
"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'. Add this page to your favorite Social Bookmarking websites ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |